Product Information

METFORMIN HCL 500 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0148 per EA under NDC 59651085405. Its NADAC has been published 85 times since Apr 9, 2025.

FDA first approved this application on Jan 14, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METFORMIN HCL 500 MG TABLET

Metformin Hydrochloride
$0.0148per EA

Strength

500 mg/1

NDC

59651085405

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

METFORMIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA077095

FDA Approved

1/14/2005

TE Code

AB

On Market Since

3/29/2024

Pharmacological Classes

Biguanide
Biguanides

Price Statistics

The NADAC for METFORMIN HCL 500 MG TABLET has been published 85 times since Apr 9, 2025, and over the history we have for it it has risen 6.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0148 per EA
All-time high$0.0148 (Nov 11, 2026)
All-time low$0.0139 (Apr 23, 2025)
52-week high$0.0148
52-week low$0.0139
Median price$0.0141
Average price$0.0142
Largest weekly change-3.2% (Dec 17, 2025)
Weeks tracked85
Tracking sinceApr 9, 2025

Price History

1W

-0.1%

1M

+2.1%

3M

+4.4%

6M

+6.1%

1Y

+1.4%

3Y

N/A

5Y

N/A

All

+6.5%

Generic Alternatives

The matcher finds 21 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of METFORMIN HCL 500 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL 500 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0148 per EA (NDC 59651085405), effective Nov 18, 2026.

How has the price of METFORMIN HCL 500 MG TABLET changed over time?

Over the history we have for it, the NADAC for METFORMIN HCL 500 MG TABLET has risen 6.5%. It has been tracked across 85 weekly CMS publications since Apr 9, 2025.

What are the highest and lowest recorded NADAC prices for METFORMIN HCL 500 MG TABLET?

Since Apr 9, 2025, the NADAC for METFORMIN HCL 500 MG TABLET has ranged from a low of $0.0139 (Apr 23, 2025) to a high of $0.0148 (Nov 11, 2026), with a median of $0.0141 per EA.

Are there cheaper alternatives to METFORMIN HCL 500 MG TABLET?

Yes. 21 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METFORMIN HCL 500 MG TABLET, is $0.0148 per EA — about 0% below METFORMIN HCL 500 MG TABLET.

Who manufactures METFORMIN HCL 500 MG TABLET?

METFORMIN HCL 500 MG TABLET (NDC 59651085405) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.